204 related articles for article (PubMed ID: 35623362)
1. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
[TBL] [Abstract][Full Text] [Related]
2. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
Shah AH; Mahavadi A; Di L; Sanjurjo A; Eichberg DG; Borowy V; Figueroa J; Luther E; de la Fuente MI; Semonche A; Ivan ME; Komotar RJ
J Neurooncol; 2020 Jul; 148(3):501-508. PubMed ID: 32627128
[TBL] [Abstract][Full Text] [Related]
4. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
[TBL] [Abstract][Full Text] [Related]
5. What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?
Gallet C; Clavreul A; Morandi X; Delion M; Madec N; Menei P; Lemée JM
J Neurooncol; 2022 Nov; 160(2):445-454. PubMed ID: 36326944
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
7. Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.
Ghinda D; Zhang N; Lu J; Yao CJ; Yuan S; Wu JS
Neurosurg Focus; 2016 Mar; 40(3):E14. PubMed ID: 26926054
[TBL] [Abstract][Full Text] [Related]
8. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
9. The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.
Li YC; Chiu HY; Lin YJ; Chen KT; Hsu PW; Huang YC; Chen PY; Wei KC
Clin Neurol Neurosurg; 2021 Jan; 200():106343. PubMed ID: 33158628
[TBL] [Abstract][Full Text] [Related]
10. Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study.
Otsuji R; Hata N; Funakoshi Y; Kuga D; Togao O; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Sako A; Kikuchi K; Yoshitake T; Yamamoto H; Mizoguchi M; Yoshimoto K
Neurol Med Chir (Tokyo); 2023 Aug; 63(8):364-374. PubMed ID: 37423755
[TBL] [Abstract][Full Text] [Related]
11. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A
J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795
[TBL] [Abstract][Full Text] [Related]
12. Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study.
Gerritsen JKW; Viëtor CL; Rizopoulos D; Schouten JW; Klimek M; Dirven CMF; Vincent AJE
Acta Neurochir (Wien); 2019 Feb; 161(2):307-315. PubMed ID: 30617715
[TBL] [Abstract][Full Text] [Related]
13. Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.
Fukui A; Muragaki Y; Saito T; Nitta M; Tsuzuki S; Asano H; Kawamata T
Acta Neurochir (Wien); 2022 Feb; 164(2):395-404. PubMed ID: 34605985
[TBL] [Abstract][Full Text] [Related]
14. An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme.
Glenn CA; Baker CM; Conner AK; Burks JD; Bonney PA; Briggs RG; Smitherman AD; Battiste JD; Sughrue ME
World Neurosurg; 2018 Jun; 114():e747-e755. PubMed ID: 29555603
[TBL] [Abstract][Full Text] [Related]
15. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
16. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Versyck G; Jessurun CAC; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Tewarie RN; Smith TR; Dirven CMF; De Vleeschouwer S; Vincent AJPE; Broekman MLD
Neuro Oncol; 2023 May; 25(5):958-972. PubMed ID: 36420703
[TBL] [Abstract][Full Text] [Related]
17. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
18. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
Schneider M; Potthoff AL; Keil VC; Güresir Á; Weller J; Borger V; Hamed M; Waha A; Vatter H; Güresir E; Herrlinger U; Schuss P
J Neurooncol; 2019 Oct; 145(1):143-150. PubMed ID: 31485921
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
